Scale-up of viral load (VL) monitoring for HIV-infected patients on antiretroviral therapy (ART) is a priority in many resource-limited settings, and ART providers are critical to effective program implementation. We explored provider-perceived barriers and facilitators of VL monitoring. We interviewed all providers (n=17) engaged in a public health evaluation of dried blood spots for VL monitoring at five ART clinics in Malawi. All ART clinics were housed within district hospitals. We grouped themes at patient, provider, facility, system, and policy levels. Providers emphasized their desire for improved ART monitoring strategies, and frustration in response to restrictive policies for determining which patients were eligible to receive VL ...
The advent of the potent combination antiretroviral therapy (cART) in 1996, often called HAART (high...
Monitoring of HIV viral load in patients on combination antiretroviral therapy (ART) is not generall...
Abstract Background Regular mo...
Scale-up of viral load (VL) monitoring for HIV-infected patients on antiretroviral therapy (ART) is ...
Despite extraordinary advances in antiretroviral therapy (ART) coverage, only a fraction of the mill...
For HIV-positive individuals on antiretroviral therapy (ART), the World Health Organization (WHO) re...
Poor access to HIV viral load (VL) testing prevents the timely monitoring of HIV treatment adherence...
Introduction Routine viral load (VL) testing among persons living with Human Immunodeficiency Virus...
BACKGROUND: Although considered an essential tool for monitoring the effect of combination antiretro...
Introduction Consequences of lack of viral monitoring in predicting the effects of development of HI...
INTRODUCTION: As antiretroviral therapy (ART) is scaled up, more patients become eligible for routin...
Background: Regular monitoring of HIV patients who are receiving antiretroviral therapy (ART) is req...
Although it is a standard practice in high-income countries, determination of the human immunodefici...
Access to antiretroviral therapy (ART) is expanding at a rapid rate in resource-limited settings, wi...
IntroductionViral load (VL) assessment is the preferred method for diagnosing and confirming virolog...
The advent of the potent combination antiretroviral therapy (cART) in 1996, often called HAART (high...
Monitoring of HIV viral load in patients on combination antiretroviral therapy (ART) is not generall...
Abstract Background Regular mo...
Scale-up of viral load (VL) monitoring for HIV-infected patients on antiretroviral therapy (ART) is ...
Despite extraordinary advances in antiretroviral therapy (ART) coverage, only a fraction of the mill...
For HIV-positive individuals on antiretroviral therapy (ART), the World Health Organization (WHO) re...
Poor access to HIV viral load (VL) testing prevents the timely monitoring of HIV treatment adherence...
Introduction Routine viral load (VL) testing among persons living with Human Immunodeficiency Virus...
BACKGROUND: Although considered an essential tool for monitoring the effect of combination antiretro...
Introduction Consequences of lack of viral monitoring in predicting the effects of development of HI...
INTRODUCTION: As antiretroviral therapy (ART) is scaled up, more patients become eligible for routin...
Background: Regular monitoring of HIV patients who are receiving antiretroviral therapy (ART) is req...
Although it is a standard practice in high-income countries, determination of the human immunodefici...
Access to antiretroviral therapy (ART) is expanding at a rapid rate in resource-limited settings, wi...
IntroductionViral load (VL) assessment is the preferred method for diagnosing and confirming virolog...
The advent of the potent combination antiretroviral therapy (cART) in 1996, often called HAART (high...
Monitoring of HIV viral load in patients on combination antiretroviral therapy (ART) is not generall...
Abstract Background Regular mo...